These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 25571727)

  • 1. [Progress of ultrasound microbubble contrast technology in the diagnosis and treatment of clinical diseases].
    Qiu L; Leng QY; Luo Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 Nov; 45(6):974-8. PubMed ID: 25571727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical applications of contrast-enhanced ultrasound].
    Dai Q; Jiang YX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Feb; 30(1):1-4. PubMed ID: 18361043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasound microbubble contrast agents for diagnostic and therapeutic applications: current status and future design.
    Kang ST; Yeh CK
    Chang Gung Med J; 2012; 35(2):125-39. PubMed ID: 22537927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbubble contrast agents: targeted ultrasound imaging and ultrasound-assisted drug-delivery applications.
    Klibanov AL
    Invest Radiol; 2006 Mar; 41(3):354-62. PubMed ID: 16481920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular applications of contrast-enhanced ultrasound imaging.
    Mehta KS; Lee JJ; Taha AG; Avgerinos E; Chaer RA
    J Vasc Surg; 2017 Jul; 66(1):266-274. PubMed ID: 28390769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasound contrast agents and ultrasound molecular imaging.
    Wen Q; Wan S; Liu Z; Xu S; Wang H; Yang B
    J Nanosci Nanotechnol; 2014 Jan; 14(1):190-209. PubMed ID: 24730259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbubble-mediated ultrasound drug-delivery and therapeutic monitoring.
    Sennoga CA; Kanbar E; Auboire L; Dujardin PA; Fouan D; Escoffre JM; Bouakaz A
    Expert Opin Drug Deliv; 2017 Sep; 14(9):1031-1043. PubMed ID: 27892760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microbubbles as ultrasound contrast agents and in targeted drug delivery.
    Sheffield P; Trehan A; Boyd B; Wong OL
    Crit Rev Biomed Eng; 2008; 36(4):225-55. PubMed ID: 19961426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbubbles as ultrasound contrast agents for molecular imaging: preparation and application.
    Unnikrishnan S; Klibanov AL
    AJR Am J Roentgenol; 2012 Aug; 199(2):292-9. PubMed ID: 22826389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasound microbubble contrast agents: application to therapy for peripheral vascular disease.
    Hu YZ; Zhu JA; Jiang YG; Hu B
    Adv Ther; 2009 Apr; 26(4):425-34. PubMed ID: 19381521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel technology: microfluidic devices for microbubble ultrasound contrast agent generation.
    Lin H; Chen J; Chen C
    Med Biol Eng Comput; 2016 Sep; 54(9):1317-30. PubMed ID: 27016369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic use of ultrasound targeted microbubble destruction: a review of non-cardiac applications.
    Bekeredjian R; Katus HA; Kuecherer HF
    Ultraschall Med; 2006 Apr; 27(2):134-40. PubMed ID: 16612722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolving applications for contrast ultrasound.
    Lindner JR
    Am J Cardiol; 2002 Nov; 90(10A):72J-80J. PubMed ID: 12450594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbubble Agents: New Directions.
    Stride E; Segers T; Lajoinie G; Cherkaoui S; Bettinger T; Versluis M; Borden M
    Ultrasound Med Biol; 2020 Jun; 46(6):1326-1343. PubMed ID: 32169397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of individual microbubbles of ultrasound contrast agents: imaging of free-floating and targeted bubbles.
    Klibanov AL; Rasche PT; Hughes MS; Wojdyla JK; Galen KP; Wible JH; Brandenburger GH
    Invest Radiol; 2004 Mar; 39(3):187-95. PubMed ID: 15076011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contrast-enhanced ultrasound combined targeted microbubbles for diagnosis of highly aggressive papillary thyroid carcinoma.
    Ma J; Wang Y; Xi X; Tang J; Wang L; Wang L; Wang D; Liang X; Zhang B
    Front Endocrinol (Lausanne); 2023; 14():1052862. PubMed ID: 36936158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrasound microbubble contrast agents: fundamentals and application to gene and drug delivery.
    Ferrara K; Pollard R; Borden M
    Annu Rev Biomed Eng; 2007; 9():415-47. PubMed ID: 17651012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of Contrast Agent Microbubbles for Ultrasound Imaging and Therapy Research.
    Mulvana H; Browning RJ; Luan Y; de Jong N; Tang MX; Eckersley RJ; Stride E
    IEEE Trans Ultrason Ferroelectr Freq Control; 2017 Jan; 64(1):232-251. PubMed ID: 27810805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of microcirculation by contrast-enhanced ultrasound: a new approach in vascular medicine.
    Kaspar M; Partovi S; Aschwanden M; Imfeld S; Baldi T; Uthoff H; Staub D
    Swiss Med Wkly; 2015; 145():w14047. PubMed ID: 25588141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted ultrasound contrast agents for ultrasound molecular imaging and therapy.
    van Rooij T; Daeichin V; Skachkov I; de Jong N; Kooiman K
    Int J Hyperthermia; 2015 Mar; 31(2):90-106. PubMed ID: 25707815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.